R&I affirms Sumitomo Dainippon Pharma's rating at "A" and announces stable outlook -R&I
Oct 3(Reuters) - Sumitomo Dainippon Pharma Co Ltd <4506.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A" -R&I.Rating outlook stable -R&I.
Latest Developments forSumitomo Chemical Co Ltd
- Sumitomo Chemical Co to buy stake exceeding 80% in Botanical Resources Australia - Nikkei
- Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda (Lurasidone Hydrochloride) in Europe
- Nufarm extends agreements with Sumitomo Chemical Co
- Monsanto and Valent U.S.A. announce partnership in roundup Ready Plus Crop Management Solutions